Association of the fat mass and obesity-associated (FTO) gene variant (rs9939609) with dietary intake in the Finnish Diabetes Prevention Study. 2012

Tiina Lappalainen, and Jaana Lindström, and Jussi Paananen, and Johan G Eriksson, and Leila Karhunen, and Jaakko Tuomilehto, and Matti Uusitupa
Department of Clinical Nutrition, Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio Campus, PO Box 1627, FI-70211 Kuopio, Finland. tiina.lappalainen@uef.fi

A cluster of variants in the fat mass and obesity-associated (FTO) gene are associated with the common form of obesity. Well-documented dietary data are required for identifying how the genetic risk can be modified by dietary factors. The objective of the present study was to investigate the associations between the FTO risk allele (rs9939609) and dietary intake, and to evaluate how dietary intake affects the association between FTO and BMI in the Finnish Diabetes Prevention Study during a mean follow-up of 3·2 years. A total of 479 (BMI >25 kg/m2) men and women were genotyped for rs9939609. The participants completed a 3 d food record at baseline and before every annual study visit. The average intakes at baseline and during the years 1, 2 and 3 were calculated. At baseline, the FTO variant rs9939609 was not associated with the mean values of total energy intake, macronutrients or fibre. At baseline, a higher BMI by the FTO risk genotype was detected especially in those who reported a diet high in fat with mean BMI of 30·6 (sd 4·1), 31·3 (sd 4·6) and 34·5 (sd 6·2) kg/m2 for TT, TA and AA carriers, respectively (P =0·005). Higher BMI was also observed in those who had a diet low in carbohydrates (P =0·028) and fibre (P =0·015). However, in the analyses adjusted for total energy intake, age and sex, significant interactions between FTO and dietary intakes were not found. These findings suggest that the association between the FTO genotype and obesity is influenced by the components of dietary intake, and the current dietary recommendations are particularly beneficial for those who are genetically susceptible for obesity.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D004435 Eating The consumption of edible substances. Dietary Intake,Feed Intake,Food Intake,Macronutrient Intake,Micronutrient Intake,Nutrient Intake,Nutritional Intake,Ingestion,Dietary Intakes,Feed Intakes,Intake, Dietary,Intake, Feed,Intake, Food,Intake, Macronutrient,Intake, Micronutrient,Intake, Nutrient,Intake, Nutritional,Macronutrient Intakes,Micronutrient Intakes,Nutrient Intakes,Nutritional Intakes
D005260 Female Females
D005387 Finland A country in northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia. The capital is Helsinki. Aland Islands,Åland Islands
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Tiina Lappalainen, and Jaana Lindström, and Jussi Paananen, and Johan G Eriksson, and Leila Karhunen, and Jaakko Tuomilehto, and Matti Uusitupa
March 2008, Journal of lipid research,
Tiina Lappalainen, and Jaana Lindström, and Jussi Paananen, and Johan G Eriksson, and Leila Karhunen, and Jaakko Tuomilehto, and Matti Uusitupa
September 2016, Journal of genetics,
Tiina Lappalainen, and Jaana Lindström, and Jussi Paananen, and Johan G Eriksson, and Leila Karhunen, and Jaakko Tuomilehto, and Matti Uusitupa
December 2018, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals,
Tiina Lappalainen, and Jaana Lindström, and Jussi Paananen, and Johan G Eriksson, and Leila Karhunen, and Jaakko Tuomilehto, and Matti Uusitupa
June 2012, Addiction (Abingdon, England),
Tiina Lappalainen, and Jaana Lindström, and Jussi Paananen, and Johan G Eriksson, and Leila Karhunen, and Jaakko Tuomilehto, and Matti Uusitupa
January 2019, Diabetes, metabolic syndrome and obesity : targets and therapy,
Tiina Lappalainen, and Jaana Lindström, and Jussi Paananen, and Johan G Eriksson, and Leila Karhunen, and Jaakko Tuomilehto, and Matti Uusitupa
January 2011, Journal of obesity,
Tiina Lappalainen, and Jaana Lindström, and Jussi Paananen, and Johan G Eriksson, and Leila Karhunen, and Jaakko Tuomilehto, and Matti Uusitupa
January 2022, Diabetes & metabolic syndrome,
Tiina Lappalainen, and Jaana Lindström, and Jussi Paananen, and Johan G Eriksson, and Leila Karhunen, and Jaakko Tuomilehto, and Matti Uusitupa
January 2022, Food & nutrition research,
Tiina Lappalainen, and Jaana Lindström, and Jussi Paananen, and Johan G Eriksson, and Leila Karhunen, and Jaakko Tuomilehto, and Matti Uusitupa
February 2015, European review for medical and pharmacological sciences,
Tiina Lappalainen, and Jaana Lindström, and Jussi Paananen, and Johan G Eriksson, and Leila Karhunen, and Jaakko Tuomilehto, and Matti Uusitupa
January 2018, Medical principles and practice : international journal of the Kuwait University, Health Science Centre,
Copied contents to your clipboard!